muller stem cell therapy (UCL institute of ophthalmology/Apollo therapeutics)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namemuller stem cell therapy (UCL institute of ophthalmology/Apollo therapeutics)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Retinal stem cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRetinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUCL Institute of Ophthalmology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUCL Institute of OphthalmologyApollo Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsRetinal Diseases

Other Information

ATC CodeN/A
Related LinksN/A